Panobinostat and donor lymphocyte infusions in patients with high-risk AML and MDS
Do patients with CLL require CAR T-cell therapy?
iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies
An overview of EBMT 2017 by Prof. Mohamad Mohty
The rising cost of drugs and how to address it